The Pierre Fabre Group is the third largest independent pharmaceutical company in France with a culture of research and innovation, ethical and pharmaceutical rigour, and a commitment to public health for over 50 years.
Founded and its headquarters still based in the south-west of France, Pierre Fabre currently has branches in 44 countries and distribution agreements in over 130 countries.
With 13,000 employees across the globe who share a passion for innovation and excellence in the areas of medication, family health and dermo-cosmetics.
The Group achieved a turnover of €2.319 Billion in 2017, with international sales accounting for 53%.
Every year, the group allocates 20% of its drug revenues to R&D, focusing on three main areas: oncology, dermatology and neuropsychiatry.
To learn more about the group, please visit our international website: https://www.pierre-fabre.com
